Table of Contents Author Guidelines Submit a Manuscript
Advances in Medicine
Volume 2016, Article ID 9242031, 6 pages
http://dx.doi.org/10.1155/2016/9242031
Research Article

Antifungal Susceptibility Patterns of Candida Species Recovered from Endotracheal Tube in an Intensive Care Unit

1Department of Microbiology, Faculty of Science, Islamic Azad University, Varamin-Pishva Branch, Tehran, Iran
2Department of Medical Parasitology and Mycology, Kurdistan University of Medical Sciences, P.O. Box 14155-6446, Sanandaj, Iran
3Division of Molecular Biology, Department of Medical Mycology and Parasitology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
4Department of Microbiology, Faculty of Science, Islamic Azad University, North Tehran Branch, Tehran, Iran
5Department of Medical Mycology, Jondishapour University of Medical Sciences, Ahvaz, Iran
6Department of Medical Mycology, Tarbiat Modares University, Tehran, Iran
7Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

Received 20 April 2016; Revised 11 June 2016; Accepted 15 June 2016

Academic Editor: Anastasia Kotanidou

Copyright © 2016 Elham Baghdadi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. P. Wenzel, “Nosocomial candidemia: risk factors and attributable mortality,” Clinical Infectious Diseases, vol. 20, no. 6, pp. 1531–1534, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Khodavaisy, M. Nabili, B. Davari, and M. Vahedi, “Evaluation of bacterial and fungal contamination in the health care workers' hands and rings in the intensive care unit,” Journal of Preventive Medicine and Hygiene, vol. 52, no. 4, pp. 215–218, 2011. View at Google Scholar · View at Scopus
  3. L. J. Douglas, “Candida biofilms and their role in infection,” Trends in Microbiology, vol. 11, no. 1, pp. 30–36, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Gudlaugsson, S. Gillespie, K. Lee et al., “Attributable mortality of nosocomial candidemia, revisited,” Clinical Infectious Diseases, vol. 37, no. 9, pp. 1172–1177, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Afshar, S. Khodavaisy, S. Kalhori, M. Ghasemi, and T. Razavyoon, “Onychomycosis in North-East of Iran,” Iranian Journal of Microbiology, vol. 6, no. 2, pp. 98–103, 2014. View at Google Scholar
  6. P. K. Mukherjee and J. Chandra, “Candida biofilm resistance,” Drug Resistance Updates, vol. 7, no. 4-5, pp. 301–309, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. E. M. Kojic and R. O. Darouiche, “Candida infections of medical devices,” Clinical Microbiology Reviews, vol. 17, no. 2, pp. 255–267, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Aliyali, M. Hedayati, M. Habibi, and S. Khodavaisy, “Clinical risk factors and bronchoscopic features of invasive aspergillosis in intensive care unit patients,” Journal of Preventive Medicine and Hygiene, vol. 54, no. 2, pp. 80–82, 2013. View at Google Scholar · View at Scopus
  9. G. S. Baillie and L. J. Douglas, “Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents,” Journal of Antimicrobial Chemotherapy, vol. 46, no. 3, pp. 397–403, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Chandra, P. K. Mukherjee, S. D. Leidich et al., “Antifungal resistance of Candidal biofilms formed on denture acrylic in vitro,” Journal of Dental Research, vol. 80, no. 3, pp. 903–908, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. S. A. Yazdanparast, S. Khodavaisy, H. Fakhim et al., “Molecular characterization of highly susceptible Candida africana from vulvovaginal candidiasis,” Mycopathologia, vol. 180, no. 5-6, pp. 317–323, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Jain, R. Kohli, E. Cook, P. Gialanella, T. Chang, and B. C. Fries, “Biofilm formation by and antifungal susceptibility of Candida isolates from urine,” Applied and Environmental Microbiology, vol. 73, no. 6, pp. 1697–1703, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J.-L. Vincent, E. Anaissie, H. Bruining et al., “Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care,” Intensive Care Medicine, vol. 24, no. 3, pp. 206–216, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Mirhendi, K. Makimura, M. Khoramizadeh, and H. Yamaguchi, “A one-enzyme PCR-RFLP assay for identification of six medically important Candida species,” Nippon Ishinkin Gakkai Zasshi, vol. 47, no. 3, pp. 225–229, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Wayne, “Reference method for broth dlution antifungal susceptibility testing of yeasts fungi,” Approved Standard M38-A2, 2008. View at Google Scholar
  16. S. Khodavaisy, M. Alialy, O. S. Mahdavi et al., “The study on fungal colonization of respiratory tract in patients admitted to intensive care units of sari and babol hospitals,” Medical Journal of Mashhad University of Medical Sciences, vol. 54, no. 3, pp. 177–184, 2011. View at Google Scholar
  17. S. H. Fesharaki, I. Haghani, B. Mousavi, M. L. Kargar, M. Boroumand, and M. S. Anvari, “Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser,” Journal of Medical Microbiology, vol. 62, no. 11, pp. 1763–1767, 2013. View at Google Scholar
  18. I. Bitar, R. A. Khalaf, H. Harastani, and S. Tokajian, “Identification, typing, antifungal resistance profile, and biofilm formation of Candida albicans isolates from Lebanese hospital patients,” BioMed Research International, vol. 2014, Article ID 931372, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Bruder-Nascimento, C. H. Camargo, A. L. Mondelli, M. F. Sugizaki, T. Sadatsune, and E. Bagagli, “Candida species biofilm and Candida albicans ALS3 polymorphisms in clinical isolates,” Brazilian Journal of Microbiology, vol. 45, no. 4, pp. 1371–1377, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Silva, M. Henriques, A. Martins, R. Oliveira, D. Williams, and J. Azeredo, “Biofilms of non-Candida albicansCandida species: quantification, structure and matrix composition,” Medical Mycology, vol. 47, no. 7, pp. 681–689, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Z. Mahmoudabadi, M. Zarrin, and N. Kiasat, “Biofilm formation and susceptibility to amphotericin B and fluconazole in Candida albicans,” Jundishapur Journal of Microbiology, vol. 7, no. 7, Article ID e17105, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Laal Kargar, S. Fooladi-Rad, M. Mohammad Davoodi et al., “Fungal colonization in patients with cystic fibrosis,” Journal of Mazandaran University of Medical Sciences, vol. 22, no. 2, pp. 204–218, 2013. View at Google Scholar
  23. P. Badiee and A. Alborzi, “Susceptibility of clinical Candida species isolates to antifungal agents by E-test, Southern Iran: a five year study,” Iranian Journal of Microbiology, vol. 3, no. 4, pp. 183–188, 2011. View at Google Scholar · View at Scopus
  24. N. Papon, V. Courdavault, M. Clastre, and R. J. Bennett, “Emerging and emerged pathogenic Candida species: beyond the Candida albicans paradigm,” PLoS Pathogens, vol. 9, no. 9, Article ID e1003550, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. S. S. Richter, R. P. Galask, S. A. Messer, R. J. Hollis, D. J. Diekema, and M. A. Pfaller, “Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases,” Journal of Clinical Microbiology, vol. 43, no. 5, pp. 2155–2162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. C. S. Aher, “Species distribution, virulence factors and antifungal susceptibility profile of Candida isolated from oropharyngeal lesions of HIV infected patients,” International Journal of Current Microbiology and Applied Sciences, vol. 3, no. 1, pp. 453–460, 2014. View at Google Scholar
  27. T. Shokohi, Z. Bandalizadeh, M. T. Hedayati, and S. Mayahi, “In vitro antifungal susceptibility of Candida species isolated from oropharyngeal lesions of patients with cancer to some antifungal agents,” Jundishapur Journal of Microbiology, vol. 4, no. 2, pp. S19–S26, 2011. View at Google Scholar
  28. S. C. Deorukhkar and S. Saini, “Non albicans Candida species: its isolation pattern, species distribution, virulence factors and antifungal susceptibility profile,” International Journal of Medical Science and Public Health, vol. 2, no. 3, pp. 533–538, 2013. View at Google Scholar
  29. S. C. Deorukhkar, S. Saini, and S. Mathew, “Non-albicans Candida infection: an emerging threat,” Interdisciplinary Perspectives on Infectious Diseases, vol. 2014, Article ID 615958, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Arendrup, E. Dzajic, R. Jensen et al., “Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme,” Clinical Microbiology and Infection, vol. 19, no. 8, pp. E343–E353, 2013. View at Publisher · View at Google Scholar
  31. M. A. Pfaller, S. A. Messer, L. N. Woosley, R. N. Jones, and M. Castanheira, “Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance,” Journal of Clinical Microbiology, vol. 51, no. 8, pp. 2571–2581, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Wiebusch, D. Lonchiati, L. Rodrigues, C. Dantas, A. Almeida, and K. Oliveira, “Profile susceptibility to fluconazole and voriconazole antifungals by species of Candida albicans isolated from urine culture,” BMC Proceedings, vol. 8, supplement 4, article P34, 2014. View at Publisher · View at Google Scholar
  33. A. L. Njunda, D. S. Nsagha, J. C. Assob, H. L. Kamga, and P. Teyim, “In vitro antifungal susceptibility patterns of Candida albicans from HIV and AIDS patients attending the Nylon Health District Hospital in Douala, Cameroon,” Journal of Public Health in Africa, vol. 3, no. 1, p. 2, 2012. View at Publisher · View at Google Scholar
  34. N. T. Wabe, J. Hussein, S. Suleman, and K. Abdella, “In vitro antifungal susceptibility of Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus in Ethiopia,” Retrovirology, vol. 9, supplement 1, p. P44, 2012. View at Publisher · View at Google Scholar
  35. R. C. Roy, G. D. Sharma, S. R. Barman, and S. Chanda, “Trend of Candida infection and antifungal resistance in a tertiary care hospital of north east India,” Blood, vol. 100, p. 19, 2013. View at Google Scholar
  36. A. Al-Mamari, M. Al-Buryhi, M. A. Al-Heggami, and S. Al-Hag, “Identify and sensitivity to antifungal drugs of Candida species causing vaginitis isolated from vulvovaginal infected patients in Sana'a city,” Der Pharma Chemica, vol. 6, no. 1, pp. 336–342, 2014. View at Google Scholar · View at Scopus
  37. A. Awari, “Species distribution and antifungal susceptibility profile of Candida isolated from urine samples,” International Journal of Applied and Basic Medical Research, vol. 18, pp. 228–234, 2011. View at Google Scholar
  38. L. Zhang, S. Zhou, A. Pan, J. Li, and B. Liu, “Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013,” International Journal of Infectious Diseases, vol. 33, pp. e1–e4, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. M. E. Bosco-Borgeat, C. G. Taverna, S. Cordoba et al., “Prevalence of candida dubliniensis fungemia in argentina: identification by a novel multiplex PCR and comparison of different phenotypic methods,” Mycopathologia, vol. 172, no. 5, pp. 407–414, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Haddadi, S. Zareifar, P. Badiee et al., “Yeast colonization and drug susceptibility pattern in the pediatric patients with neutropenia,” Jundishapur Journal of Microbiology, vol. 7, no. 9, Article ID e11858, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Silva, M. Negri, M. Henriques, R. Oliveira, D. W. Williams, and J. Azeredo, “Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance,” FEMS Microbiology Reviews, vol. 36, no. 2, pp. 288–305, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. F. C. Bizerra, C. Jimenez-Ortigosa, A. C. R. Souza et al., “Breakthrough candidemia due to multidrug-resistant Candida glabrata during prophylaxis with a low dose of micafungin,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 4, pp. 2438–2440, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. L. X. Bonfietti, M. D. A. Martins, M. W. Szeszs et al., “Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis bloodstream isolates,” Journal of Medical Microbiology, vol. 61, part 7, pp. 1003–1008, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. S. T. Tay, S. L. Na, and J. Chong, “Molecular differentiation and antifungal susceptibilities of Candida parapsilosis isolated from patients with bloodstream infections,” Journal of Medical Microbiology, vol. 58, no. 2, pp. 185–191, 2009. View at Publisher · View at Google Scholar · View at Scopus